摘要
目的 探讨连续动态血糖监测对妊娠期糖尿病孕妇妊娠结局的影响。方法 选择2020年1月至2021年6月诊治30例妊娠期糖尿病孕妇,根据血糖监测方法不同分为对照组和观察组研究组。对照组(n=14)予常规末梢血糖监测,研究组(n=16)则采用雅培瞬感动态血糖仪进行连续性动态血糖监测,比较两组干预前后血糖目标范围内时间(TIR)与糖化血红蛋白,并对比孕产妇与围产儿结局。结果 研究组干预后TIR(77.42±6.23)%,高于对照组;糖化血红蛋白(6.31±0.53)%,小于对照组,比较差异具有统计学意义(P<0.05)。研究组羊水过多、早产、胎盘早剥、新生儿低血糖发生率18.75%、0.00%、0.00%、6.25%,低于对照组57.14%、35.71%、35.71%、50.00%,比较差异具有统计学意义(P<0.05)。结论 对妊娠期糖尿病孕妇予连续动态血糖监测能够有效监测血糖波动,血糖控制更为及时有效,可降低不良妊娠结局发生风险,值得推广。
Objective To investigate the effect of continuous dynamic blood glucose monitoring on pregnancy outcome of pregnant women with gestational diabetes mellitus. Methods Thirty pregnant women with gestational diabetes mellitus diagnosed and treated from January 2020 to June 2021 were selected and divided into control group and study group according to different blood glucose monitoring methods. The control group(n=14) was given routine peripheral blood glucose monitoring, and the study group(n=16) was used Abbott transient continuous blood glucose meter for continuous continuous blood glucose monitoring.haemoglobin and comparing maternal and perinatal outcomes. Results After intervention, the TIR in the study group was(77.42±6.23)%, which was higher than that in the control group;the glycated hemoglobin was(6.31±0.53)%, which was lower than that in the control group, and the difference was statistically significant(P<0.05). The incidence rates of polyhydramnios, premature birth, placental abruption, and neonatal hypoglycemia in the study group were 18.75%, 0.00%, 0.00%, and 6.25%, which were lower than those in the control group, which were 57.14%, 35.71%, 35.71%, and 50.00%, and the differences were statistically significant.Academic significance(P<0.05).Thirty pregnant women with gestational diabetes mellitus from January 2020 to September 2021were selected and divided into control group and observation group according to different blood glucose monitoring methods. The control group(n=14) was given routine peripheral blood glucose monitoring, and the observation group(n=16) was used Abbott transient continuous blood glucose meter for continuous continuous blood glucose monitoring. haemoglobin and comparing maternal and perinatal outcomes. Results After intervention, the TIR in the observation group was(77.42±6.23)%, which was higher than that in the control group;the glycated hemoglobin was(6.31±0.53)%, which was lower than that in the control group, and the difference was statistically significant(P<0.05). The incidence rates of polyhydramnios, premature birth, placental abruption, and neonatal hypoglycemia in the observation group were 18.75%, 0.00%, 0.00%, and 6.25%, which were lower than those in the control group, which were 57.14%, 35.71%, 35.71%, and 50.00%, and the differences were statistically significant. Academic significance(P<0.05). Conclusion Continuous dynamic blood glucose monitoring for pregnant women with GESTational diabetes can effectively monitor blood glucose fluctuations, control blood glucose more timely and effective, and reduce the risk of adverse pregnancy outcomes, which is worthy of promotion.
作者
陈英姿
缪丛庆
刘敬敬
赵越
Chen Yingzi;Miao Congqing;Liu Jingjing;Zhao Yue(Department of Endocrinology,Yangzhou Jiangdu People's Hospital,Yangzhou,Jiangsu Province 225200,China)
出处
《实用妇科内分泌电子杂志》
2021年第19期87-89,共3页
Electronic Journal of Practical Gynecological Endocrinology
关键词
妊娠期糖尿病
连续动态血糖监测
末梢血糖监测
妊娠结局
Gestational diabetes mellitus
Continuous dynamic blood glucose monitoring
Peripheral blood glucose monitoring
Pregnancy outcomes